Actuate Therapeutics
We are a clinical biotech company developing GSK-3 inhibitor drugs to treat metastatic pancreatic cancer. (Incorporated in Delaware) We are focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is designed to […]
June 11, 2024 Read More